eGenesis Raises $125M in Series C Financing

03 Mar, 2021

eGenesis Raises $125M in Series C Financing
Photo by Matthew Fournier on Unsplash

– eGenesis from Cambridge, Mass. develops human-compatible organs, tissues, and cells.
– The company raised $125m in Series C funding.
– Backers included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Invus, Samsara BioCapital, LifeSci Venture Partners, Irving Investors, Catalio Capital Management, SymBiosis, Altium Capital, Monashee Investment Management, and Osage University Partners and existing investors Leaps by Bayer, Fresenius Medical Care Ventures, ARCH Venture Partners, Wellington Partners, Khosla Ventures, and Alta Partners.

Biopharma Biotechnology Genetics Life Science Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: